ArticleObesity surgery2026
Combined Proximal Revision and Moderate Distalization After Roux-en-Y Gastric Bypass: A Retrospective Single-Center Case Series.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSuboptimal initial clinical response (SICR) and recurrent weight gain (RWG) after Roux-en-Y gastric bypass (RYGB) pose significant clinical challenges. More aggressive malabsorptive conversions enhance weight loss but are associated with increased metabolic risk. This study reports single-center descriptive outcomes of a combined revision of RYGB (CR-RYGB), consisting of proximal revision with a moderate type 1 distalization.
methodsThis retrospective single-center case series includes 163 consecutive patients who underwent CR-RYGB between October 2019 and January 2025. Perioperative characteristics, postoperative morbidity, and longitudinal weight-loss outcomes were descriptively analyzed.
resultsMean pre-revision BMI was 41.35 kg/m², with a mean follow-up of 14.3 months. Indications were SICR (12.3%), formal RWG (82.2%), and less significant RWG (5.5%). No intraoperative complications or conversions occurred. Proximal revision consisted of gastrojejunal sleeve (87.1%), pouch resizing (5.5%), or redo gastrojejunostomy (7.4%), with additional banding in 45.4%. Mean total alimentary limb length after type 1 distalization was 507cm. Early and late postoperative complication rates were 3.7% and 6.7%, respectively. Two patients required reoperation (one for malnutrition, one for intractable steatorrhea). Mean percentage total weight loss was 20.3% at 12 months, 22.2% at 2 years, 24.5% at 3 years, and 22.2% at 4 years.
conclusionIn this retrospective single-center case series, CR-RYGB had low postoperative morbidity and sustained weight loss during follow-up. These descriptive findings support the hypothesis that CR-RYGB may provide balance between weight loss and metabolic risk compared with more aggressive distalization alone. However, no conclusions regarding comparative safety or efficacy can be drawn, warranting prospective controlled studies.
Indexed as
Identifiers
41845021What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.